Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001087582 | SCV000637057 | likely benign | Brugada syndrome | 2024-10-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000841399 | SCV000983362 | likely benign | not provided | 2020-06-16 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002341309 | SCV002637566 | likely benign | Cardiovascular phenotype | 2020-02-27 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002506329 | SCV002805107 | likely benign | Brugada syndrome 2 | 2021-08-10 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001700203 | SCV001919362 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001700203 | SCV001926629 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000841399 | SCV001959049 | likely benign | not provided | no assertion criteria provided | clinical testing |